Inhaled Corticosteroid Market

Asthma is a disease of the entire respiratory tract, including large, intermediate and small airways. Asthma led to inflammation and obstruction of respiratory tract. Patients have various treatment options for asthma, particularly for young and elderly patients. Hence this has led to significant interest on the part of the inhaler device which is easy to use. Inhaled corticosteroid is the most commonly used tool for the treatment of asthma. As with increasing pollution and increasing incidences of asthma, many companies are engaged in the development of new inhaler corticosteroid devices.
Inhaled Corticosteroid Market aims to provide a comprehensive presentation of the global market for Inhaled Corticosteroid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Inhaled Corticosteroid. Inhaled Corticosteroid Market contains market size and forecasts of Inhaled Corticosteroid in global, including the following market information:
Global Inhaled Corticosteroid Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Inhaled Corticosteroid Market Sales, 2018-2023, 2024-2030, (MT)
Global top five Inhaled Corticosteroid companies in 2022 (%)
The global Inhaled Corticosteroid market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In terms of market value, North America will dominate the inhaler corticosteroid device market during the forecast period. Increasing incidences of life-threatening illness such as chronic obstructive pulmonary disease, asthma and many more are some of the factors which are responsible for the growth of the market during the forecast period.
We surveyed the Inhaled Corticosteroid manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inhaled Corticosteroid Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (MT)
Global Inhaled Corticosteroid Market Segment Percentages, by Type, 2022 (%)
Beclomethasone Dipropionate
Budesonide
Fluticasone Inhaler Powder
Mometasone
Others
Global Inhaled Corticosteroid Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (MT)
Global Inhaled Corticosteroid Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Respiratory Care Centers
Others
Global Inhaled Corticosteroid Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (MT)
Global Inhaled Corticosteroid Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Inhaled Corticosteroid revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Inhaled Corticosteroid revenues share in global market, 2022 (%)
Key companies Inhaled Corticosteroid sales in global market, 2018-2023 (Estimated), (MT)
Key companies Inhaled Corticosteroid sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sumitomo
Pfizer
Novartis
Merck
Sanofi
Johnson and Johnson
GSK
AstraZeneca
Teijin
Glaxo's Advair
Amgen
Kos Pharmaceutical
Teva Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Inhaled Corticosteroid, market overview.
Chapter 2: Global Inhaled Corticosteroid market size in revenue and volume.
Chapter 3: Detailed analysis of Inhaled Corticosteroid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Inhaled Corticosteroid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Inhaled Corticosteroid capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.